Clinical Trial Update: Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on camrelizumab and apatinib as neoadjuvant therapy for thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Fudan University | Conditions: Thyroid Cancer | Phase 2 | Status: UNKNOWN